Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myelo001 phase IIa study in chemotherapy-induced neutropenia
ISRCTN10853057Phase 2Completed
- Sponsor
- Myelo Therapeutics
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of Ingavirin in chemotherapy-induced neutropenia (CIN) and myelosuppression (2 arms), sponsored by Myelo Therapeutics. Started Mar 2016; status: completed.
02
Drugs
Ingavirin
03
Conditions
chemotherapy-induced neutropenia (CIN)myelosuppression
Beyond the preview
Go deeper on ISRCTN10853057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10853057.